Chitwood, D. D., Sanchez, J., Comerford, M., McCoy, C. B. Primary preventative health care among injection drug users, other sustained drug users, and nonusers. Subst Use Misuse 2001 May–June; 36(6–7):807–24.CrossRefGoogle Scholar

Chitwood, D. D., McBride, D. C., French, M. T., Comerford, M. Health care need and utilization: A preliminary comparison of injection drug users, other illicit drug users, and nonusers. Subst Use Misuse 1999 Mar–Apr; 34(4–5):727–46.Google Scholar

Herron, A. J., Brennan, T. K. The ASAM Essentials of Addiction Medicine. Philadelphia, PA: Wolters Kluwer and American Society of Addiction Medicine; 2015.Google Scholar

Raja, S., Hasnain, M., Hoersch, M., Gove-Yin, S., Raiagopalan, C. Trauma informed care in medicine: current knowledge and future research. Fam Community Health 2015; 38(2):216–26.CrossRefGoogle Scholar

Shekarchizadeh, H., Khami, M. R., Mohebbi, S. Z., Ekhtiari, H., Virtanen, J. I. Oral health of drug abusers: a review of health effects and care. Iran J Public Health 2013; 42(9):929–40.Google ScholarPubMed

Kramer, A., Lorenzon, D., Mueller, G. Prevalence of intimate partner violence and health implications for women using emergency departments and primary care clinics. Womens Health Issues 2004; 14(1):19–29.CrossRefGoogle ScholarPubMed

Isaac, N. E., Pualani Enos, V. Documenting Domestic Violence: How Health Care Providers Can Help Victims. National Institute of Justice Research in Brief. September 2001.CrossRefGoogle Scholar

Gibson, D. R., Flynn, N. M., Perales, D. Effectiveness of syringe exchange program in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 2001; 15:1329–41.Google Scholar

Wurcel, A. G., Merchant, E. A., Clark, R. P., Stone, D. R. Emerging and underrecognized complications of illicit drug use. Goldstein, EJC, ed. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2015; 61(12):1840–9. doi: 10.1093/cid/civ689.Google Scholar

Connolly, C., O'Donoghue, K., Doran, H., McCarthy, F. P. Infective endocarditis in pregnancy: Case report and review of the literature. Obstet Med 2015; 8(2):102–4.Google Scholar

Wolff, A. J., O'Donnell, A. E. Pulmonary effects of illicit drug use. Clin Chest Med 2004 Mar; 25(1):203–16.CrossRefGoogle ScholarPubMed

Mégarbane, B., Chevillard, L. The large spectrum of pulmonary complications following illicit drug use: features and mechanisms. Chem Biol Interact 2013 Dec 5; 206(3):444–51.Google Scholar

Centers for Disease Control and Prevention (2013) HIV in the United States: At a Glance. Available at: www.cdc.gov/hiv/pdf/statistics_basics_factsheet.pdf. Retrieved November 20, 2016.Google Scholar

Tyndall, M. W., Patrick, D., Spittal, P., Li, K., O'Shaughnessy, M. V. Risky sexual behaviors among injection drug users with high HIV prevalence: implications for STD control. Sex Transm Infect 2002; 78(Suppl 1):i170–5.CrossRefGoogle ScholarPubMed

Salemi, J. L., Spooner, K. K., Meija de Grubb, M. C., et al. National trends of Hepatitis B and C during pregnancy across sociodemographic, behavioral, and clinical factors, United States, 1998–2011. J Med Virol 2017; 89(6):1025–32. Wiley Online Library. Retrieved December 3, 2016.CrossRefGoogle Scholar

Dionne-Odom, J., Tita, A. T., Silverman, N. S. Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. Am J Obstet Gynecol 2016; 214(1):6–14.Google Scholar

Lin, K., Vickery, J. Screening for hepatitis B virus infection in pregnant women: evidence for the US Preventative Task For reaffirmation recommendation statement. Ann Intern Med 2009; 150:874–6.CrossRefGoogle ScholarPubMed

Pergam, S. A., Wang, C. C., Gardella, C. M., et al. Pregnancy complications associate with hepatitis C: data from a 2003–2005 Washington state birth cohort. Am J Obstet Gynecol 2008; 199:38.Google Scholar

Fernandez, N., Towers, C. V., Wolf, L., et al. Sharing of snorting straws and hepatitis C infection in pregnant women. Obstet Gynecol 2016; 128:234–7.CrossRefGoogle ScholarPubMed

Conte, D., Fraquelli, M., Prati, D., et al. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000; 31:751–5.Google Scholar

Prasad, M. R. Hepatitis C virus screening in pregnancy: Is it time to change our practice? Am Coll Obstet Gynecol 2016; 128(2):229–30.Google Scholar

Kanninen, T. T., Dieterich, D., Asciutti, S. HCV vertical transmission in pregnancy: New horizons in the era of DAAs. Hepatology 2015; 62:1656–8.CrossRefGoogle ScholarPubMed

Centers for Disease Control and Prevention. Guidelines for Vaccinating Pregnant Women, Hepatitis A. 2014. Available at: www.cdc.gov/vaccines/pubs/preg-guide.htm#hepa. Retrieved August 31, 2016.Google Scholar

Centers for Disease Control and Prevention. HIV Basics. Available at: www.cdc.gov/hiv/basics/statistics.html. Retrieved December 4 2016.Google Scholar

Centers for Disease Control and Prevention. Report of the NIH Panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR Morb Wkly Rep 1998; 47(RR-5):1–82.Google Scholar

Mofeson, L. M., Lambert, J. S., Stiehm, E. R., et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999; 341:385–93.Google Scholar

ACOG Committee Opinion Scheduled Cesarean Delivery and the Prevention of Vertical Transmission of HIV Infection. May 2000. Number 234.Google Scholar

Connor, E. M., Perling, R. S., Gelber, R., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331:1173–80.CrossRefGoogle Scholar

Garcia, P. M., Kalish, L. A., Pitts, J., et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999; 341:349–402.CrossRefGoogle ScholarPubMed

Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Available at: http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf. Retrieved February 01, 2017.Google Scholar

Seigfried, N., van der Merwe, L., Brocklehurst, P., Sint, T. T. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev 2011; (7): Art. No.: CD003510.Google Scholar

Sebitloane, H. M., Moodley, D. The impact of highly active antiretroviral therapy on obstetric conditions: A review. Eur J Obstet Gynecol Reprod Biol 2017; 210:126–31.CrossRefGoogle ScholarPubMed

Green, T. C., Grimes-Serrano, J. M., Licari, A., Budman, S. H., Butler, S. F. Women who abuse prescription opioids: Findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug Alcohol Depend 2009; 103:65–73.Google Scholar

Cicero, T. J., Wong, G., Tian, Y., et al. Co-morbidity and utilization of medical services by pain patients receiving opioid medications: Data from an insurance claims database. Pain 2009; 144:20–7.Google Scholar

Rementeria, J. L., Nuang, N. N. Narcotic withdrawal in pregnancy: Stillbirth incident with a case report. Am J Obstet Gynecol 1973; 116:1152–6.Google Scholar

Zuspan, F. P., Gumpel, J. A., Meija-Zelaya, A., Madden, J., Davis, R. Fetal stress from methadone withdrawal. Am J Obstet Gynecol 1975; 122:43–6.CrossRefGoogle ScholarPubMed

Stewart, R. D., Nelson, D. B., Adhikari, E. H., et al. The obstetrical and neonatal impact of maternal opioid detoxification in pregnancy. Am J Obstet Gynecol 2013; 209:267. e1–5.Google Scholar

Dashe, J. S., Sheffield, J. S., Olschler, D. A., Zane, E. H., Wendel, G. D. Opioid detoxification in pregnancy. Obstet Gynecol 1998; 92:854–8.Google Scholar

Bell, J., Towers, C. V., Henessy, M. D., et al. Detoxification from opiate drugs during pregnancy. Am J Obstet Gynecol 2016; 215:374. e1–6.CrossRefGoogle ScholarPubMed

Luty, J., Nikolaou, V., Bearn, J. Is opiate detoxification unsafe in pregnancy? J Subst Abuse Tret 2004; 24:363–7.Google Scholar

Sullivan, M. D., Turner, J. A., DiLodovico, C., et al. Prescription opioid taper support for outpatients with chronic pain: a randomized controlled trial. J Pain 2016;10:1–25.Google Scholar

Fiellen, D. A., Schottenfeld, M. D., Cutter, C. J., et al. Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence. JAMA Intern Med 2014; 174(12):1947–54.Google Scholar